Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
GSK said it would pay $500 million upfront for rights to an experimental COPD drug from Jiangsu Hengrui Pharmaceuticals, the latest example of a pharma company turning to a Chinese firm to build out its pipeline
Ferguson GP, Booth IR: Importance of glutathione for growth and survival of Escherichia coli cells: detoxification of methylglyoxal and maintenance of intracellular K+
Can BPC-157 Influence VEGF, Angiogenesis, and Blood Vessel Repair
Safety Profile: Common Side Effects : Nausea, vomiting, and diarrhea are the most commonly reported side effects
The move is expected to save the state an estimated $240 million
)
US$ 20.42
)
)
)
US$ 22.20
US$ 24.38
US$ 26.34
US$ 20.70
US$ 25.19
US$ 20.67
